Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1988-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1210/JCEM-67-5-876PMID 3182962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells

  2007cited by this paper
• Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.

  1986cited by this paper
• Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

  1986cited by this paper
• Calciuric response to 1,25-(OH)2D3 in early renal failure.

  1985cited by this paper
• Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.

  1985cited by this paper
• 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture.

  1985cited by this paper
• Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D.

  1985cited by this paper
• On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency.

  1985cited by this paper
• Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

  1984cited by this paper
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

  1984cited by this paper
• The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects.

  1984cited by this paper
• Determinants of serum 1,25(OH)2D levels in renal disease.

  1983cited by this paper
• Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.

  1983cited by this paper
• Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure.

  1982cited by this paper
• Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency.

  1982cited by this paper
• Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteodystrophy.

  1980cited by this paper
• Impaired parathyroid hormone metabolism in patients with chronic renal failure.

  1978cited by this paper
• Bone histology in incipient and advanced renal failure.

  1976cited by this paper
• Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands.

  1975cited by this paper
• On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

  1974cited by this paper
• Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects.

  1973cited by this paper
• Study of intestinal absorption of calcium in patients with renal failure.

  1973cited by this paper
• Hyperparathyroidism and renal failure.

  1973cited by this paper
• The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

  1973cited by this paper
• On the pathogenesis of the uremic state--an exposition of the trade-off hypothesis.

  1972cited by this paper
• On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog.

  1971cited by this paper
• Experience with a radioimmunoassay of parathyroid hormone in human sera.

  1968cited by this paper

• Association of Secondary Hyperparathyroidism and Hyperkalemia in Hemodialysis-dependent Chronic Kidney Disease Patients

  2024cites this paper
• Evaluating the effects of uric acid level reduction on serum vitamin D level in hemodialysis patients

  2023cites this paper
• Assessment the efficacy and safety of denosumab use for treatment of osteoporosis in hemodialysis patients

  2022cites this paper
• Total and free vitamin D metabolites in patients with primary hyperparathyroidism

  2021cites this paper
• Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System

  2021cites this paper
• Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.

  2021cites this paper
• INCIDENCE OF IRREGULAR PARATHYROID HORMONE IN PATIENTS OF RENAL FAILURE PLANNED TO UNDERGO HEMODIALYSIS

  2021cites this paper
• Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation

  2020cites this paper
• Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting

  2020cites this paper
• Potential Risk Factors for Mortality Due to Cardiovascular Disease Among Hemodialysed Patients in Indonesia

  2020cites this paper
• Linking chronic kidney disease and Parkinson’s disease: a literature review

  2020cites this paper
• The impact of sunlight exposure on mortality of patients with end stage renal disease

  2019cites this paper
• Chronic kidney disease : determining chronicity, prevalence, variation and survival in a community chronic kidney disease (CKD) cohort

  2018cites this paper
• The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

  2018cites this paper
• Klotho and Postmenopausal Hormone Replacement Therapy in Women with Chronic Kidney Disease

  2018cites this paper
• Determination of NF-κB and RANKL levels in peripheral blood osteoclast precursor cells in chronic kidney disease patients

  2018cites this paper
• Efficacy and Safety of Denosumab for the Treatment of Osteoporosis in Patients with Chronic Kidney Disease

  2017cites this paper
• Vitamin Deficiency Among the Elderly Institutionalized Patients

  2017cites this paper
• Traditional herbal and non-steroidal anti-inflammatory analgesic (NSAIAs) usage and its association with chronic kidney disease (CKD) in Northern Saudi Arabia

  2017cites this paper
• Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease

  2017cites this paper
• Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis

  2017cites this paper
• Vitamin D Deficiency and Supplementation in Cardiovascular Disorders.

  2017cites this paper
• University of Groningen The Vitamin D – Fibroblast Growth Factor 23 – Klotho Axis and Progression of Chronic Kidney Disease

  2017cites this paper
• Calcium and Bone Metabolism Indices.

  2017cites this paper
• Effects of vitamin D receptor activators on vascular calcification in patients with CKD

  2017cites this paper
• Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism

  2017cites this paper
• Investigating the role of hyperparathyroidism in the cardiovascular burden of chronic kidney disease

  2017cites this paper
• The Vitamin D – Fibroblast Growth Factor 23 – Klotho Axis and Progression of Chronic Kidney Disease

  2017cites this paper
• Hormonal and Mineral Changes in Early Stages of Chronic Kidney Diseases

  2016cites this paper
• Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low

  2016cites this paper
• Changes in Glomerular Filtration Rate and Its Relation to Serum Calcium Level in Advanced Stages of Chronic Kidney Disease

  2015cites this paper
• Association of genetic and Biochemical markers with GFR among renal failure patients : Applying Serum Creatinine and Cystatin C measures

  2015cites this paper
• The prevalence of vitamin D deficiency in pre-dialysis patients with chronic kidney disease

  2015cites this paper
• Benefits of Selective Vitamin D Receptor Activators in Kidney Transplanted Patients

  2015cites this paper
• Study on changes in glomerular filtration rate (GFR) and its relation to Serum inorganic phosphate level in advanced stages of chronic kidney disease

  2015cites this paper
• Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule

  2015cites this paper
• Prevalence of Secondary Hyperparathyroidism among Hemodialysis Patients in Three Royal Medical Services Centers

  2015cites this paper
• Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A German-Austrian, Single-Arm, Open-Label, Prospective, Noninterventional, Observational Study

  2014cites this paper
• Prevalence Estimates of Chronic Kidney Disease in Hail Region, KSA: In a Comprehensive Survey

  2014cites this paper
• Disordered FGF23 and mineral metabolism in children with CKD.

  2014cites this paper
• Phosphate Homeostasis and Metabolic Bone Disease

  2014cites this paper
• ROLE OF CINACALCET PLUS CALCITRIOL FOR SECONDARY HYPERPARATHYROIDISM IN PATIENTS RECEIVING HEMODIALYSIS

  2014cites this paper
• Vitamin D deficiency among the elderly: insights from Qatar

  2014cites this paper
• Evaluation of some biochemical parameters in relation to acute renal failure

  2014cites this paper
• Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients

  2013cites this paper
• A prospective randomized pilot study on intermittent post-dialysis dosing of cinacalcet

  2013cites this paper
• Association of Bone Mineral Density with Albuminuria and Estimated Glomerular Filtration Rate : The Dong-gu Study

  2013cites this paper
• Bone mineral density in patients with predialysis chronic kidney disease

  2013cites this paper
• Chronic kidney disease: mineral and bone disorder in children.

  2013cites this paper
• Renal Bone Disease Among Patients With ESRD

  2013cites this paper
• Fibroblast growth factor 23 (FGF-23) concentrations in cats with early nonazotemic chronic kidney disease (CKD) and in healthy geriatric cats.

  2013cites this paper
• A Narrow-Band Ultraviolet B Course Improves Vitamin D Balance and Alters Cutaneous CYP27A1 and CYP27B1 mRNA Expression Levels in Haemodialysis Patients Supplemented with Oral Vitamin D

  2013cites this paper
• Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction

  2012cites this paper
• Prevalence of diminished kidney function in a representative sample of middle and older age adults in the Irish population

  2012cites this paper
• [Guidelines on bone mineral disorder in chronic kidney disease--addendum chapter 2].

  2012cites this paper
• Chronic kidney disease in postmenopausal women

  2012cites this paper
• Parathyroid hormone concentration in geriatric cats with various degrees of renal function.

  2012influential citation
• Narrow-band ultraviolet B exposure increases serum vitamin D levels in haemodialysis patients.

  2012cites this paper
• Vitamin D, obesity and risk of diabetes

  2012cites this paper
• Deficiência da Vitamina D na população insuficiente renal crónica: impacto clínico e intervenção terapêutica.

  2012cites this paper
• Relationship between parathyroid hormone and electrolytes in chronic kidney disease

  2012cites this paper
• Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients

  2012cites this paper
• Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial.

  2012cites this paper
• Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD.

  2012cites this paper
• BIOCHEMICAL CORRELATES OF RENAL DYSFUNCTION AMONG NON-DIABETIC HYPERTENSIVES

  2012cites this paper
• A Stepped Care Approach to the Management of Chronic Kidney Disease

  2012cites this paper
• Vitamin D supplementation in CKD.

  2011cites this paper
• Impact of Chronic Kidney Disease on the Presence and Severity of Aortic Stenosis in Patients at High Risk for Coronary Artery Disease

  2011cites this paper
• Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC.

  2011cites this paper
• Prevalence of Diagnosis and Staging of Chronic Kidney Disease by Primary Care Providers in a Rural State

  2011cites this paper
• Secondary hyperparathyroidism and target organs in chronic kidney disease.

  2011cites this paper
• Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patients.

  2011cites this paper
• Serum 25-Hydroxyvitamin D Levels and Prediabetes Among Subjects Free of Diabetes

  2011cites this paper
• Intravenous Alfacalcidol Once Weekly Pulse Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients

  2011cites this paper
• Estimation and Comparison of Serum Levels of Sodium, Potassium, Calcium and Phosphorus in Different Stages of Chronic Kidney Disease

  2011cites this paper
• [Prevention and treatment of secondary hyperparathyroidism in CKD].

  2011cites this paper
• Vitamin K2 Improves Renal Function and Increases Femoral Bone Strength in Rats with Renal Insufficiency

  2011cites this paper
• Prevenção e tratamento do hiperparatireoidismo secundário na DRC

  2011cites this paper
• Factors influencing vitamin D status.

  2011cites this paper
• [Prevention and treatment of secondary hyperparathyroidism in CKD].

  2011cites this paper
• Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.

  2010cites this paper
• Associations between serum leptin level and bone turnover in kidney transplant recipients.

  2010cites this paper
• Cinacalcet effect on severe hyperparathyroidism.

  2010cites this paper
• Mini-Review Control of Secondary Hyperparathyroidism by Vitamin D Receptor Agonists in Chronic Kidney Disease

  2010cites this paper
• Treatment of secondary hyperparathyroidism in chronic kidney disease, and its effect on the QT interval

  2010cites this paper
• Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.

  2010cites this paper
• Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content.

  2010cites this paper
• Ageing and changes in phosphate transport: clinical implications.

  2010cites this paper
• Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.

  2010cites this paper
• Predictive equations, oxidative and metabolic risk factors among Ghanaian patients presenting with chronic kidney disease

  2010cites this paper
• Prevence a léčba sekundární hyperparatyreózy při chronickém onemocnění ledvin

  2010cites this paper
• Arti Altered Divalent Ion Metabolism in Different Stages of Chronic Renal failure

  2009cites this paper
• 25‐Hydroxyvitamin D levels in prevalent Australian dialysis patients

  2009cites this paper
• Association of serum phosphate with vascular and valvular calcification in moderate CKD.

  2009cites this paper
• Risk factors of hyperparathyroidism in advanced stages of chronic kidney disease.

  2009cites this paper
• Glomerular filtration rate and serum phosphate : an inverse relationship diluted by age

  2009cites this paper
• The Functional Metabolism and Molecular Biology of Vitamin D Action

  2009cites this paper
• Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate.

  2009cites this paper
• Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

  2009cites this paper
• Timing of onset of CKD-related metabolic complications.

  2009cites this paper